NL MIND-BEST: A web server for ligands and proteins discovery-Theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum

Journal of Theoretical Biology

Volumn 276, Issue 1, 2011, Pages 229-249

  González Díaz, Humberto ^a   Prado Prado, Francisco ^a   Sobarzo Sánchez, Eduardo ^a   Haddad, Mohamed ^b,c,d   Maurel Chevalley, Séverine ^b,c   Valentin, Alexis ^b,c   Quetin Leclercq, Joëlle ^d   Dea Ayuela, María A ^e   Teresa Gomez Muños, María ^e   Munteanu, Cristian R ^f   José Torres Labandeira, Juan ^a   García Mera, Xerardo ^a   Tapia, Ricardo A ^g   Ubeira, Florencio M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c IRD LPSNPR   (France)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^f UNIVERSITY OF A CORUÑA   (Spain)

^g PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Drugs targets prediction; Ligands protein interaction; Markov model; Multi target QSAR; Protein structure networks

Indexed keywords

ALKALOID DERIVATIVE; ANTIMALARIAL AGENT; ANTIPARASITIC AGENT; APORPHINE DERIVATIVE; CLORSULON; CLOSANTEL; DIAMFENETIDE; DIETHYLCARBAMAZINE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; PIPERAZINE; PRAZIQUANTEL; PROTEOME; PROTOZOAL PROTEIN;

ARTIFICIAL NEURAL NETWORK; EXPERIMENTAL STUDY; LIGAND; MARKOV CHAIN; MODEL VALIDATION; MODELING; PROTEIN; THEORETICAL STUDY;

ACCESS TO INFORMATION; ACCURACY; ANIMAL CELL; ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; FEMALE; GIARDIA LAMBLIA; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; ONLINE ANALYSIS; PEPTIDE ANALYSIS; PLASMODIUM FALCIPARUM; PREDICTION; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN TARGETING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REFERENCE DATABASE; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL ELECTROPHORESIS; VALIDATION STUDY; WEB BROWSER;

ANTIMALARIALS; APORPHINES; ARTIFICIAL INTELLIGENCE; CELL DEATH; COMPUTATIONAL BIOLOGY; DRUG EVALUATION, PRECLINICAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GIARDIA LAMBLIA; HELA CELLS; HUMANS; INTERNET; LIGANDS; MASS SPECTROMETRY; MODELS, CHEMICAL; MOLECULAR DYNAMICS SIMULATION; NEURAL NETWORKS (COMPUTER); NONLINEAR DYNAMICS; PEPTIDES; PLASMODIUM FALCIPARUM; PROTEOME; PROTOZOAN PROTEINS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; ROC CURVE;

GIARDIA INTESTINALIS; PLASMODIUM FALCIPARUM;

EID: 79952327303     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2011.01.010     Document Type: Article

References (151)

1. Aguero-Chapin G., Antunes A., Ubeira F.M., Chou K.C., Gonzalez-Diaz H. Comparative study of topological indices of macro/supramolecular RNA complex networks. J. Chem. Inf. Model. 2008, 48:2265-2277.
2. Aguero-Chapin G., Varona-Santos J., de la Riva G.A., Antunes A., Gonzalez-Villa T., Uriarte E., Gonzalez-Diaz H. Alignment-free prediction of polygalacturonases with pseudofolding topological indices: experimental isolation from Coffea arabica and prediction of a new sequence. J. Proteome Res. 2009, 8:2122-2128.
3. Agüero-Chapin G., Gonzalez-Diaz H., Molina R., Varona-Santos J., Uriarte E., Gonzalez-Diaz Y. Novel 2D maps and coupling numbers for protein sequences. The first QSAR study of polygalacturonases; isolation and prediction of a novel sequence from Psidium guajava L. FEBS Lett. 2006, 580:723-730.
4. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., J.L.D. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25:389-402.
5. Apte A.A., Cain J.W., Bonchev D.G., Fong S.S. Cellular automata simulation of topological effects on the dynamics of feed-forward motifs. J. Biol. Eng. 2008, 2:2.
6. Arakaki T., Le Trong I., Phizicky E., Quartley E., DeTitta G., Luft J., Lauricella A., Anderson L., Kalyuzhniy O., Worthey E., Myler P.J., Kim D., Baker D., Hol W.G., Merritt E.A. Structure of Lmaj006129AAA, a hypothetical protein from Leishmania major. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2006, 62:175-179.
7. Barabasi A.L. Sociology. Network theory-the emergence of the creative enterprise. Science 2005, 308:639-641.
8. Barabasi A.L. Network medicine-from obesity to the "diseasome". N. Engl. J. Med. 2007, 357:404-407.
9. Barabasi A.L., Oltvai Z.N. Network biology: understanding the cell′s functional organization. Nat. Rev. Genet. 2004, 5:101-113.
10. a values for protein-ligand complexes. Proteins 2008, 73:765-783.
11. Bleakley K., Yamanishi Y. Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics 2009, 25:2397-2403.
12. Bonchev D. On the complexity of directed biological networks. SAR QSAR Environ. Res. 2003, 14:199-214.
13. Bonchev D. Complexity analysis of yeast proteome network. Chem. Biodivers. 2004, 1:312-326.
14. Bonchev D., Buck G.A. From molecular to biological structure and back. J. Chem. Inf. Model. 2007, 47:909-917.
15. Bonchev D., Thomas S., Apte A., Kier L.B. Cellular automata modelling of biomolecular networks dynamics, SAR QSAR. Environ. Res. 2010, 21:77-102.
16. Bornholdt S., Schuster H.G. Handbook of Graphs and Complex Networks: From the Genome to the Internet 2003, WILEY-VCH GmbH & CO., KGa, Wheinheim.
17. Boustie J., Stigliani J.L., Montanha J., Amoros M., Payard M., Girre L. Antipoliovirus structure-activity relationships of some aporphine alkaloids. J. Nat. Prod. 1998, 61:480-484.
18. Caballero J., Fernandez M. Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and Bayesian-regularized neural networks. J. Mol. Model. 2006, 12:168-181.
19. Camacho M.R., Kirby G.C., Warhurst D.C., Croft S.L., Phillipson J.D. Oxoaporphine alkaloids and quinones from Stephania dinklagei and evaluation of their antiprotozoal activities. Planta Med. 2000, 66:478-480.
20. Campillos M., Kuhn M., Gavin A.C., Jensen L.J., Bork P. Drug target identification using side-effect similarity. Science 2008, 321:263-266.
21. Chen X., Fang Y., Yao L., Chen Y., Xu H. Does drug-target have a likeness?. Methods Inf. Med. 2007, 46:360-366.
22. Chou K.C. Prediction of G-protein-coupled receptor classes. J. Proteome Res. 2005, 4:1413-1418.
23. Chou K.C., Elrod D.W. Bioinformatical analysis of G-protein-coupled receptors. J. Proteome Res. 2002, 1:429-433.
24. Chou K.C., Elrod D.W. Prediction of enzyme family classes. J. Proteome Res. 2003, 2:183-190.
25. Chou K.C., Shen H.B. Predicting eukaryotic protein subcellular location by fusing optimized evidence-theoretic K-nearest neighbor classifiers. J. Proteome Res. 2006, 5:1888-1897.
26. Chou K.C., Shen H.B. Large-scale predictions of Gram-negative bacterial protein subcellular locations. J. Proteome Res. 2006, 5:3420-3428.
27. Chou, K.C., Shen, H.B., 2007. MemType-2L: a web server for predicting membrane proteins and their types by incorporating evolution information through Pse-PSSM. Biochem. Biophys. Res. Commun., doi: 10.1016/j.bbrc.2007.1006.1027.
28. Chou K.C., Shen H.B. Cell-PLoc: a package of Web servers for predicting subcellular localization of proteins in various organisms. Nat. Protoc. 2008, 3:153-162.
29. Clemente J.C., Govindasamy L., Madabushi A., Fisher S.Z., Moose R.E., Yowell C.A., Hidaka K., Kimura T., Hayashi Y., Kiso Y., Agbandje-McKenna M., Dame J.B., Dunn B.M., McKenna R. Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor. Acta Crystallogr. D Biol. Crystallogr. 2006, 62:246-252.
30. Concu R., Podda G., Uriarte E., Gonzalez-Diaz H. Computational chemistry study of 3D-structure-function relationships for enzymes based on Markov models for protein electrostatic, HINT, and van der Waals potentials. J. Comput. Chem. 2009, 30:1510-1520.
31. Concu R., Podda G., Ubeira F.M., Gonzalez-Diaz H. Review of QSAR models for enzyme classes of drug targets: theoretical background and applications in parasites, hosts, and other organisms. Curr. Pharm. Des. 2010, 16:2710-2723.
32. Concu R., Dea-Ayuela M.A., Perez-Montoto L.G., Bolas-Fernandez F., Prado-Prado F.J., Podda G., Uriarte E., Ubeira F.M., Gonzalez-Diaz H. Prediction of enzyme classes from 3D structure: a general model and examples of experimental-theoretic scoring of peptide mass fingerprints of Leishmania proteins. J. Proteome Res. 2009, 8:4372-4382.
33. Concu R., Dea-Ayuela M.A., Perez-Montoto L.G., Prado-Prado F.J., Uriarte E., Bolas-Fernandez F., Podda G., Pazos A., Munteanu C.R., Ubeira F.M., Gonzalez-Diaz H. 3D entropy and moments prediction of enzyme classes and experimental-theoretic study of peptide fingerprints in Leishmania parasites. Biochim. Biophys. Acta 2009, 1794:1784-1794.
34. Cully D.F., Wilkinson H., Vassilatis D.K., Etter A., Arena J.P. Molecular biology and electrophysiology of glutamate-gated chloride channels of invertebrates. Parasitology 1996, 113(Suppl.):S191-S200.
35. Dea-Ayuela M.A., Bolás-Fernández F. Two-dimensional electrophoresis and mass spectrometry for the identification of species-specific Trichinella antigens. Vet. Parasitol. 2005, 132:43-49.
36. Dea-Ayuela M.A., Perez-Castillo Y., Meneses-Marcel A., Ubeira F.M., Bolas-Fernandez F., Chou K.C., Gonzalez-Diaz H. HP-Lattice QSAR for dynein proteins: experimental proteomics (2D-electrophoresis, mass spectrometry) and theoretic study of a Leishmania infantum sequence. Bioorg. Med. Chem. 2008, 16:7770-7776.
37. Dufe V.T., Qiu W., Muller I.B., Hui R., Walter R.D., Al-Karadaghi S. Crystal structure of Plasmodium falciparum spermidine synthase in complex with the substrate decarboxylated S-adenosylmethionine and the potent inhibitors 4MCHA and AdoDATO. J Mol Biol 2007, 373:167-177.
38. Edwards S.R., Campbell A.J., Sheers M., Moore R.J., Montague P.E. Protection of Fasciola hepatica against flukicidal action of the amine of diamphenethide in vitro. Mol. Biochem. Parasitol. 1981, 2:339-348.
39. Edwards S.R., Campbell A.J., Sheers M., Moore R.J., Montague P.E. Studies of the effect of diamphenethide and oxyclozanide on the metabolism of Fasciola hepatica. Mol. Biochem. Parasitol. 1981, 2:323-338.
40. Estrada E. Protein bipartivity and essentiality in the yeast protein-protein interaction network. J. Proteome Res. 2006, 5:2177-2184.
41. Estrada E. Virtual identification of essential proteins within the protein interaction network of yeast. Proteomics 2006, 6:35-40.
42. Evans A.M., Martin R.J. Activation and cooperative multi-ion block of single nicotinic-acetylcholine channel currents of Ascaris muscle by the tetrahydropyrimidine anthelmintic, morantel. Br. J. Pharmacol. 1996, 118:1127-1140.
43. Fernandez M., Caballero J., Tundidor-Camba A. Linear and nonlinear QSAR study of N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives as matrix metalloproteinase inhibitors. Bioorg. Med. Chem. 2006, 14:4137-4150.
44. Fink H. On the problem of the minimal inhibitory concentration (MIC) of oxacillin against staphylococci. Arzneim-Forsch 1965, 15:630-632.
45. Frisch M.J.T., Kudin G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Montgomery J.A., Vreven T., Kudin K.N., Burant J.C., Millam J.M., Iyengar S.S., Tomasi J., Barone V., Mennucci B., Cossi M., Scalmani G., Rega N., Petersson G.A., Nakatsuji H., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Klene M., Li X., Knox J.E., Hratchian H.P., Cross J.B., Bakken V., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J.W., Ayala P.Y., Morokuma K., Voth G.A., Salvador P., Dannenberg J.J., Zakrzewski V.G., Dapprich S., Daniels A.D., Strain M.C., Farkas O., Malick D.K., Rabuck A.D., Raghavachari K., Foresman J.B., Ortiz J.V., Cui Q., Baboul A.G., Clifford S., Cioslowski J., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Martin R.L., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Challacombe M., Gill P.M.W., Johnson B., Chen W., Wong M.W., Gonzalez C., Pople J.A. Gaussian 03, Revision B.03 2003, Gaussian, Inc., Pittsburgh, PA.
46. Froimowitz M. HyperChem: a software package for computational chemistry and molecular modeling. BioTechniques 1993, 14:1010-1013.
47. Geppert H., Humrich J., Stumpfe D., Gartner T., Bajorath J. Ligand prediction from protein sequence and small molecule information using support vector machines and fingerprint descriptors. J. Chem. Inf. Model. 2009, 49:767-779.
48. Gharahdaghi F., Weinberg C.R., Meagher D.A., Imai B.S., Mische S.M. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20:601-605.
49. Gia O., Marciani Magno S., González-Díaz H., Quezada E., Santana L., Uriarte E., Dalla Via L. Design, synthesis and photobiological properties of 3,4-cyclopentenepsoralens. Bioorg. Med. Chem. 2005, 13:809-817.
50. Giddings M.C., Shah A.A., Gesteland R., Moore B. Genome-based peptide fingerprint scanning. Proc. Natl. Acad. Sci. USA 2003, 100:20-25.
51. Giuliani, A., 2010. Collective motions and specific effectors: a statistical mechanics perspective on biological regulation. BMC Genomics 11 (Suppl. 1), S2. doi:. http://10.1186/1471-2164-11-S1-S2.
52. Goh K.I., Cusick M.E., Valle D., Childs B., Vidal M., Barabasi A.L. The human disease network. Proc. Natl. Acad. Sci. USA 2007, 104:8685-8690.
53. Gonzalez-Diaz H. Network topological indices, drug metabolism, and distribution. Curr. Drug Metab. 2010, 11:283-284.
54. Gonzalez-Diaz H., Prado-Prado F., Ubeira F.M. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr. Top. Med. Chem. 2008, 8:1676-1690.
55. Gonzalez-Diaz H., Saiz-Urra L., Molina R., Santana L., Uriarte E. A model for the recognition of protein kinases based on the entropy of 3D van der Waals interactions. J. Proteome Res. 2007, 6:904-908.
56. Gonzalez-Diaz H., Bonet I., Teran C., De Clercq E., Bello R., Garcia M.M., Santana L., Uriarte E. ANN-QSAR model for selection of anticancer leads from structurally heterogeneous series of compounds. Eur. J. Med. Chem. 2007, 42:580-585.
57. González-Díaz H. QSAR and complex networks in pharmaceutical design, microbiology, parasitology, toxicology. Cancer Neurosci. Curr. Pharm. Des. 2010, 16:2598-2600.
58. González-Díaz H., Vilar S., Santana L., Uriarte E. Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices. Curr. Top. Med. Chem. 2007, 7:1025-1039.
59. González-Díaz H., Pérez-Castillo Y., Podda G., Uriarte E. Computational chemistry comparison of stable/nonstable protein mutants classification models based on 3D and topological indices. J. Comput. Chem. 2007, 28:1990-1995.
60. González-Díaz H., González-Díaz Y., Santana L., Ubeira F.M., Uriarte E. Proteomics, networks and connectivity indices. Proteomics 2008, 8:750-778.
61. González-Díaz H., Aguero-Chapin G., Varona-Santos J., Molina R., de la Riva G., Uriarte E. 2D RNA-QSAR: assigning ACC oxidase family membership with stochastic molecular descriptors; isolation and prediction of a sequence from Psidium guajava L. Bioorg. Med. Chem. Lett. 2005, 15:2932-2937.
62. Good A.C., Hodgkin E.E., Richards W.G. Similarity screening of molecular data sets. J. Comput. Aided Mol. Des. 1992, 6:513-520.
63. Han, L., Cui, J., Lin, H., Ji, Z., Cao, Z., Li, Y., Chen, Y., 2006. Recent progresses in the application of machine learning approach for predicting protein functional class independent of sequence similarity. Proteomics 6, 4023-4037.
64. Henderson K.A., Streltsov V.A., Coley A.M., Dolezal O., Hudson P.J., Batchelor A.H., Gupta A., Bai T., Murphy V.J., Anders R.F., Foley M., Nuttall S.D. Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure 2007, 15:1452-1466.
65. Hirosawa M., Hoshida M., Ishikawa M., Toya T. MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput. Appl. Biosci. 1993, 9:161-167.
66. Humberto González-Díaz F.P.-P.A.F.M.U. Predicting antimicrobial drugs and targets with the MARCH INSIDE approach. Curr. Top. Med. Chem. 2008, 8:1676-1690.
67. Hypercube, I., 2002. Hyperchem 7.0, Gainesville, FL, USA.
68. Hypercube.Inc Hyperchem Software. Release 7.5 for Windows, Molecular Modeling System 2002, Hypercube Inc., Gainesville, FL, USA.
69. Kier L.B., Bonchev D., Buck G.A. Modeling biochemical networks: a cellular-automata approach. Chem. Biodivers. 2005, 2:233-243.
70. Koenig T., Menze B.H., Kirchner M., Monigatti F., Parker K.C., Patterson T., Steen J.J., Hamprecht F.A., Steen H. Robust prediction of the MASCOT score for an improved quality assessment in mass spectrometric proteomics. J. Proteome Res. 2008, 7:3708-3717.
71. Lam R.L., Welch W.J. Comparison of methods based on diversity and similarity for molecule selection and the analysis of drug discovery data. Methods Mol. Biol. 2004, 275:301-316.
72. Lei Z., Elmer A.M., Watson B.S., Dixon R.A., Mendes P.J., Sumner L.W. A two-dimensional electrophoresis proteomic reference map and systematic identification of 1367 proteins from a cell suspension culture of the model legume Medicago truncatula. Mol. Cell Proteomics 2005, 4:1812-1825.
73. Leung, K.Y., Lescuyer, P.,Campbell, J., Byers, H.L., Allard, L., Sanchez, J.C., Ward, M.A., 2005. A novel strategy using MASCOT distiller for analysis of cleavable isotope-coded affinity tag data to quantify protein changes in plasma. Proteomics 5, 3040-3044.
74. Li J., Lei B., Liu H., Li S., Yao X., Liu M., Gramatica P. QSAR study of malonyl-CoA decarboxylase inhibitors using GA-MLR and a new strategy of consensus modeling. J. Comput. Chem. 2008, 29:2636-2647.
75. Li Q., Lai L. Prediction of potential drug targets based on simple sequence properties. BMC Bioinformatics 2007, 8:353.
76. Likhitwitayawuid K., Angerhofer C.K., Chai H., Pezzuto J.M., Cordell G.A., Ruangrungsi N. Cytotoxic and antimalarial alkaloids from the tubers of Stephania pierrei. J. Nat. Prod. 1993, 56:1468-1478.
77. Lin W.Z., Xiao X., Chou K.C. GPCR-GIA: a web-server for identifying G-protein coupled receptors and their families with grey incidence analysis. Protein Eng. Des. Sel. 2009, 22:699-705.
78. Liu Y., Beveridge D.L. Exploratory studies of ab initio protein structure prediction: multiple copy simulated annealing, AMBER energy functions, and a generalized born/solvent accessibility solvation model. Proteins 2002, 46:128-146.
79. Loscalzo J., Kohane I., Barabasi A.L. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol. Syst. Biol. 2007, 3:124.
80. Maeda A., Okazaki T., Inoue M., Kitazono T., Yamasaki M., Lemonnier F.A., Ozaki S. Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II. Int. Immunopharmacol. 2009, 9:1183-1188.
81. Maizels R.M., Denham D.A. Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug. Parasitology 1992, 105(Suppl.):S49-S60.
82. Managbanag J.R., Witten T.M., Bonchev D., Fox L.A., Tsuchiya M., Kennedy B.K., Kaeberlein M. Shortest-path network analysis is a useful approach toward identifying genetic determinants of longevity. PLoS One 2008, 3:e3802.
83. Marchler-Bauer A., Bryant S.H. CD-search: protein domain annotations on the fly. Nucleic Acids Res. 2004, 32:W327-W331.
84. Martin R.J. Gamma-aminobutyric acid- and piperazine-activated single-channel currents from Ascaris suum body muscle. Br. J. Pharmacol. 1985, 84:445-461.
85. Martin R.J. Neuromuscular transmission in nematode parasites and antinematodal drug action. Pharmacol. Ther. 1993, 58:13-50.
86. Martin R.J. An electrophysiological preparation of Ascaris suum pharyngeal muscle reveals a glutamate-gated chloride channel sensitive to the avermectin analogue, milbemycin D. Parasitology 1996, 112(Part 2):247-252.
87. Mascarenhas N.M., Ghoshal N. Combined ligand and structure based approaches for narrowing on the essential physicochemical characteristics for CDK4 inhibition. J. Chem. Inf. Model. 2008, 48:1325-1336.
88. Mazurie A., Bonchev D., Schwikowski B., Buck G.A. Phylogenetic distances are encoded in networks of interacting pathways. Bioinformatics 2008, 24:2579-2585.
89. Mazurie A., Bonchev D., Schwikowski B., Buck G.A. Evolution of metabolic network organization. BMC Syst. Biol. 2010, 4:59.
90. McKellar Q.A., Bogan J.A., von Fellenberg R.L., Ludwig B., Cawley G.D. Pharmacokinetic, biochemical and tolerance studies on carprofen in the horse. Equine Vet. J. 1991, 23:280-284.
91. Menk M., von Haefen C., Funke-Kaiser H., Sifringer M., Schefe J.H., Kirsch S., Seidel K., Reinemund J., Steckelings U.M., Unger T., Spies C.D. Ethanol-induced downregulation of the angiotensin AT2 receptor in murine fibroblasts is mediated by PARP-1. Alcohol 2010, 44:495-506.
92. Michel J., Verdonk M.L., Essex J.W. Protein-ligand binding affinity predictions by implicit solvent simulations: a tool for lead optimization?. J. Med. Chem. 2006, 49:7427-7439.
93. Montanha J.A., Amoros M., Boustie J., Girre L. Anti-herpes virus activity of aporphine alkaloids. Planta Med. 1995, 61:419-424.
94. Mulder, J.E., Brien, J.F., Racz, W.J.,Takahashi, T., Massey, T.E., 2011. Mechanisms of amiodarone and desethylamiodarone cytotoxicity in non-transformed human peripheral lung epithelial cells. J. Pharmacol. Exp. Ther. 336, 551-559.
95. Munoz V., Sauvain M., Mollinedo P., Callapa J., Rojas I., Gimenez A., Valentin A., Mallie M. Antimalarial activity and cytotoxicity of (-)-roemrefidine isolated from the stem bark of Sparattanthelium amazonum. Planta Med. 1999, 65:448-449.
96. Munteanu C.R., Vazquez J.M., Dorado J., Sierra A.P., Sanchez-Gonzalez A., Prado-Prado F.J., Gonzalez-Diaz H. Complex network spectral moments for ATCUN motif DNA cleavage: first predictive study on proteins of human pathogen parasites. J. Proteome Res. 2009, 8:5219-5228.
97. Naumann T., Matter H. Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. J. Med. Chem. 2002, 45:2366-2378.
98. Onnela J.P., Saramaki J., Hyvonen J., Szabo G., Lazer D., Kaski K., Kertesz J., Barabasi A.L. Structure and tie strengths in mobile communication networks. Proc. Natl. Acad. Sci. USA 2007, 104:7332-7336.
99. Park J., Barabasi A.L. Distribution of node characteristics in complex networks. Proc. Natl. Acad. Sci. USA 2007, 104:17916-17920.
100. Parr R.G., Pearson R.G. Absolute hardness: companion parameter to absolute electronegativity. J. Am. Chem. Soc. 1983, 105:7512-7516.
101. Parr R.G., Szentpály L.V., Liu S. Density Functional Theory of Atoms and Molecules 1989, Oxford University Press, New York.
102. Parr R.G., Szentpály L.V., Liu S. Electrophilicity index. J. Am. Chem. Soc. 1999, 121:1922-1924.
103. Parr R.G., Donnelly R.A., Levy M., Palke W.E. Electronegativity: the density functional viewpoint. J. Chem. Phys. 1978, 68:3801.
104. Pham T.A., Jain A.N. Parameter estimation for scoring protein-ligand interactions using negative training data. J. Med. Chem. 2006, 49:5856-5868.
105. Prado-Prado F.J., Garcia-Mera X., Gonzalez-Diaz H. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg. Med. Chem. 2010, 18:2225-2231.
106. Prado-Prado F.J., Gonzalez-Diaz H., Santana L., Uriarte E. Unified QSAR approach to antimicrobials. Part 2: predicting activity against more than 90 different species in order to halt antibacterial resistance. Bioorg. Med. Chem. 2007, 15:897-902.
107. Prado-Prado F.J., Gonzalez-Diaz H., de la Vega O.M., Ubeira F.M., Chou K.C. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Bioorg. Med. Chem. 2008, 16:5871-5880.
108. Prado-Prado F.J., Martinez de la Vega O., Uriarte E., Ubeira F.M., Chou K.C., Gonzalez-Diaz H. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorg. Med. Chem. 2009, 17:569-575.
109. Raha K., Peters M.B., Wang B., Yu N., Wollacott A.M., Westerhoff L.M., Merz K.M. The role of quantum mechanics in structure-based drug design. Drug Discovery. Today 2007, 12:725-731.
110. Redman C.A., Robertson A., Fallon P.G., Modha J., Kusel J.R., Doenhoff M.J., Martin R.J. Praziquantel: an urgent and exciting challenge. Parasitol. Today 1996, 12:14-20.
111. Réka A., Barabasi A.-L. Statistical mechanics of complex networks. Rev. Mod. Phys. 2002, 74:47-97.
112. Robertson S.J., Martin R.J. Levamisole-activated single-channel currents from muscle of the nematode parasite Ascaris suum. Br. J. Pharmacol. 1993, 108:170-178.
113. Rodriguez-Soca, Y., Munteanu, C.R., Prado-Prado, F.J., Dorado, J., Pazos Sierra, A., Gonzalez-Diaz, H., 2009a. Trypano-PPI: a web server for prediction of unique targets in trypanosome proteome by using electrostatic parameters of protein-protein interactions. J. Proteome Res., doi: 10.1021/pr900827b.
114. Rodriguez-Soca, Y., Munteanu, C.R., Dorado, J., Rabuñal, J., Pazos, A., González-Díaz, 2009b. Plasmod-PPI: a web-server predicting complex biopolymer targets in plasmodium with entropy measures of protein-protein interactions. Polymer, doi: 10.1016/j.polymer.2009.11.029.
115. Rodriguez-Soca Y., Munteanu C.R., Dorado J., Pazos A., Prado-Prado F.J., Gonzalez-Diaz H. Trypano-PPI: a web server for prediction of unique targets in trypanosome proteome by using electrostatic parameters of protein-protein interactions. J Proteome Res. 2010, 9:1182-1190.
116. Roos M.H., Kwa M.S.G., Grant W.N. New genetic and practical implications of selection for anthelmintic resistance in parasitic nematodes. Parasitol. Today 1995, 11:148-150.
117. Rudnick P.A., Wang Y., Evans E., Lee C.S., Balgley B.M. Large scale analysis of MASCOT results using a Mass Accuracy-based THreshold (MATH) effectively improves data interpretation. J. Proteome Res. 2005, 4:1353-1360.
118. Santana L., Uriarte E., Gonzalez-Diaz H., Zagotto G., Soto-Otero R., Mendez-Alvarez E. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins. J. Med. Chem. 2006, 49:1149-1156.
119. Santana L., Uriarte E., Gonzalez-Diaz H., Zagotto G., Soto-Otero R., Mendez-Alvarez E. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins. J. Med. Chem. 2006, 49:1149-1156.
120. Santana L., Gonzalez-Diaz H., Quezada E., Uriarte E., Yanez M., Vina D., Orallo F. Quantitative structure-activity relationship and complex network approach to monoamine oxidase a and B inhibitors. J. Med. Chem. 2008, 51:6740-6751.
121. Schulman M.D., Ostlind D.A., Valentino D. Mechanism of action of MK-401 against Fasciola hepatica: inhibition of phosphoglycerate kinase. Mol. Biochem. Parasitol. 1982, 5:133-145.
122. Shen H.B., Chou K.C. Nuc-PLoc: a new web-server for predicting protein subnuclear localization by fusing PseAA composition and PsePSSM. Protein Eng. Des. Sel. 2007, 20:561-567.
123. Shen H.B., Chou K.C. PseAAC: a flexible web server for generating various kinds of protein pseudo amino acid composition. Anal. Biochem. 2008, 373:386-388.
124. Sobarzo-Sanchez E., De la Fuente J., Castedo L. Synthesis and total assignment of 1H and 13C NMR spectra of new oxoisoaporphines by long-range heteronuclear correlations. Magn. Reson Chem 2005, 43(12):1080-1083.
125. StatSoft.Inc., 2002. STATISTICA (data analysis software system), version 6.0., Inc., 6.0. http://www.statsoft.com.Statsoft.
126. Sternberg M.J., King R.D., Lewis R.A., Muggleton S. Application of machine learning to structural molecular biology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1994, 344:365-371.
127. Stevigny C., Bailly C., Quetin-Leclercq J. Cytotoxic and antitumor potentialities of aporphinoid alkaloids. Curr. Med. Chem. Anticancer Agents 2005, 5:173-182.
128. Stévigny C., Block S., Pauw-Gillet M.C.D., Hoffmann E.d., Llabrès G., Adjakidjé V., Quetin-Leclercq J. Cytotoxic aporphine alkaloids from Cassytha filiformis. Planta Med. 2002, 68:1042-1044.
129. Tamura M., Takano S. Influence of pH of media on the minimal inhibitory concentration of cycloserine to Mycobacterium tuberculosis. Kekkaku 1965, 40:213-218.
130. Thimm M., Goede A., Hougardy S., Preissner R. Comparison of 2D similarity and 3D superposition. Application to searching a conformational drug database. J. Chem. Inf. Comput. Sci. 2004, 44:1816-1822.
131. Thomas S., Bonchev D. A survey of current software for network analysis in molecular biology. Hum. Genomics 2010, 4:353-360.
132. Todeschini R., Consonni V. Handbook of Molecular Descriptors 2002, Wiley-VCH.
133. Vassura M., Margara L., Di Lena P., Medri F., Fariselli P., Casadio R. Reconstruction of 3D structures from protein contact maps. IEEE/ACM Trans. Comput. Biol. Bioinform. 2008, 5:357-367.
134. Vijayan R.S., Bera I., Prabu M., Saha S., Ghoshal N. Combinatorial library enumeration and lead hopping using comparative interaction fingerprint analysis and classical 2D QSAR methods for seeking novel GABA(A) alpha(3) modulators. J. Chem. Inf. Model. 2009, 49:2498-2511.
135. Vilar S., Santana L., Uriarte E. Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action. J. Med. Chem. 2006, 49:1118-1124.
136. Vina D., Uriarte E., Orallo F., Gonzalez-Diaz H. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors. Mol. Pharm. 2009, 6:825-835.
137. Wang Y., Bajorath J. Development of a compound class-directed similarity coefficient that accounts for molecular complexity effects in fingerprint searching. J. Chem. Inf. Model. 2009, 49:1369-1376.
138. Wu Z.C., Xiao X., Chou K.C. 2D-MH: a web-server for generating graphic representation of protein sequences based on the physicochemical properties of their constituent amino acids. J. Theor. Biol. 2010, 267:29-34.
139. Xiao X., Lin W.Z. Application of protein grey incidence degree measure to predict protein quaternary structural types. Amino Acids 2009, 37:741-749.
140. Xiao X., Shao S.H., Chou K.C. A probability cellular automaton model for hepatitis B viral infections. Biochem. Biophys. Res. Commun. 2006, 342:605-610.
141. Xiao X., Lin W.Z., Chou K.C. Using grey dynamic modeling and pseudo amino acid composition to predict protein structural classes. J. Comput. Chem. 2008, 29:2018-2024.
142. Xiao X., Wang P., Chou K.C. Predicting protein structural classes with pseudo amino acid composition: an approach using geometric moments of cellular automaton image. J. Theor. Biol. 2008, 254:691-696.
143. Xiao X., Wang P., Chou K.C. GPCR-CA: a cellular automaton image approach for predicting G-protein-coupled receptor functional classes. J. Comput. Chem. 2009, 30:1414-1423.
144. Xiao, X., Wang, P., Chou, K.C., in press. Quat-2L:aweb-server for predicting protein quaternary structural attributes. Mol. Div., doi:. http://10.1007/s11030-010-9227-8.
145. Xiao X., Shao S., Ding Y., Huang Z., Chen X., Chou K.C. Using cellular automata to generate image representation for biological sequences. Amino Acids 2005, 28:29-35.
146. Xiao X., Shao S., Ding Y., Huang Z., Chen X., Chou K.C. An application of gene comparative image for predicting the effect on replication ratio by HBV virus gene missense mutation. J. Theor. Biol. 2005, 235:555-565.
147. Xie L., Xie L., Bourne P.E. A unified statistical model to support local sequence order independent similarity searching for ligand-binding sites and its application to genome-based drug discovery. Bioinformatics 2009, 25:i305-i312.
148. Yamanishi Y., Araki M., Gutteridge A., Honda W., Kanehisa M. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 2008, 24:i232-i240.
149. Yang C.Y., Sun H., Chen J., Nikolovska-Coleska Z., Wang S. Importance of ligand reorganization free energy in protein-ligand binding-affinity prediction. J. Am. Chem. Soc. 2009, 131:13709-13721.
150. Yu B.W., Meng L.H., Chen J.Y., Zhou T.X., Cheng K.F., Ding J., Qin G.W. Cytotoxic oxoisoaporphine alkaloids from Menispermum dauricum. J. Nat. Prod. 2001, 64:968-970.
151. Zhang S., Golbraikh A., Tropsha A. Development of quantitative structure-binding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces. J. Med. Chem. 2006, 49:2713-2724.